Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

AIM/RUA stock hub

AIM/RUA has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

AIM/RUAis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

14.9M

London Stock Exchange AIM

Market data

Live price

Current market quote for this ticker.

Current price

AIM/RUA

In the news

Latest news · AIM/RUA

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.9P50 16.9P75 23.5

Trailing P/En/a

P25 15.9P50 22.9P75 35.8

ROEn/a

P25 -54.2P50 2.1P75 13.7

ROICn/a

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All AIM/RUA market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

190

Groups with data

Currency

GBP

Showing 190 of 190 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United Kingdom
Country code	UK
Employees	59
Employees Change	19%
Employees Change Percent	47.5
Enterprise value	GBX 12.5M
Exchange	London Stock Exchange AIM
Financial currency	GBP
First seen	2026-05-10
Industry	Medical Devices
Isin	GB0033360586
Last refreshed	2026-05-10
Market cap	GBX 14.9M
Price	GBX 24.67
Price currency	GBX
Rev Per Employee	75,581.97x
Sector	Healthcare
Sic	3842
Symbol	aim/RUA
Website	https://rualifesciences.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-0.98%
EV Earnings	-85.87x
EV/EBITDA	45.88x
EV/FCF	-52.88x
EV/Sales	2.8x
FCF yield	-1.58%
P/B ratio	2.07x
P/S ratio	3.34x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-3.84%
EBITDA Margin	6.1%
Gross margin	77.5%
Gross Profit	GBX 3.5M
Gross Profit Growth	24.74%
Gross Profit Growth Q	73%
Gross Profit Growth3 Y	29.47%
Gross Profit Growth5 Y	15.62%
Net Income	GBX -145,333
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Pretax Margin	-3.53%
Profit Margin	-3.26%
Profit Per Employee	GBX -2,463
ROCE	-2.15

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	1.45%
Cagr15y	-12.31%
Cagr1y	105.66%
Cagr20y	-13.66%
Cagr3y	-17.23%
Cagr5y	-29.08%
EPS Growth Quarters	1
EPS Growth Years	0
Revenue Growth	74.47x
Revenue Growth Q	85.33x
Revenue Growth Years	8x
Revenue Growth3 Y	29.99x
Revenue Growth5 Y	16.25x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	GBX 9.1M
Cash	GBX 3.3M
Current Assets	GBX 5.4M
Current Liabilities	GBX 1.1M
Debt	GBX 794,000
Debt EBITDA	GBX 2.92
Debt Equity	GBX 0.11
Debt FCF	GBX -3.36
Equity	GBX 7.2M
Liabilities	GBX 1.9M
Long Term Assets	GBX 3.7M
Long Term Liabilities	GBX 830,000
Net Cash	GBX 2.5M
Net Cash By Market Cap	GBX 16.49
Net Cash Growth	-28.35%
Net Debt EBITDA	GBX -9.03
Net Debt Equity	GBX -0.34
Tangible Book Value	GBX 6.5M
Tangible Book Value Per Share	GBX 0.1
WACC	9.09

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.64
Net Working Capital	GBX 1.2M
Quick ratio	3.62
Working Capital	GBX 4.2M
Working Capital Turnover	GBX 1.02

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-42.62%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	15.52%
1Y total return	105.56%
200-day SMA	13.18
3Y total return	-43.29%
50-day SMA	15.44
50-day SMA vs 200-day SMA	50over200
5Y total return	-82.06%
All Time High	9,468
All Time High Change	-99.74%
All Time High Date	2000-11-09
All Time Low	8
All Time Low Change	208.34%
All Time Low Date	2017-03-24
ATR	1.27
Beta	0.97
Beta1y	0.75
Beta2y	0.16
Ch YTD	76.2
High	24.67
High52	24.67
High52 Date	2026-05-08
High52ch	0%
Low	20.9
Low52	10.42
Low52 Date	2025-09-17
Low52ch	136.8%
Ma50ch	59.77%
Price vs 200-day SMA	87.17%
RSI	83.38
RSI Monthly	60.48
RSI Weekly	81.08
Sharpe ratio	1.71x
Sortino ratio	3.37
Total Return	-42.62%
Tr YTD	76.2
Tr15y	-86.06%
Tr1m	93.47%
Tr1w	26.5%
Tr3m	70.12%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	GBX -171,333
Operating margin	-3.84

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	50,721,735%
Net Borrowing	-357,334
Shares Insiders	13.69%
Shares Institutions	61.99%
Shares Out	62,060,272
Shares Qo Q	0%
Shares Yo Y	42.62%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	GBX -350,000
Average Volume	387,145.5x
Bv Per Share	0.12
CAPEX	GBX -107,333
Ch10y	9.63
Ch15y	-86.77
Ch1m	93.47
Ch1w	26.5
Ch1y	105.6
Ch20y	-94.97
Ch3m	70.12
Ch3y	-43.29
Ch5y	-82.06
Ch6m	86.17
Change	20.33%
Change From Open	17.46
Close	20.5
Days Gap	2.44
Depreciation Amortization	443,334
Dollar Volume	20,134,896.2
Earnings Date	2026-06-25
EBIT	GBX -171,333
EBITDA	GBX 272,001
EPS	GBX -0
F Score	1
FCF	GBX -236,000
FCF EV Yield	-1.89x
FCF Per Share	GBX -0
Financing CF	-306,000
Fiscal Year End	September
Founded	1,996
Goodwill	301,000
Income Tax	GBX -2,000
Investing CF	-2,000
Is Primary Listing	1
Last Earnings Date	2025-12-11
Last Report Date	2025-03-31
Last Split Date	2003-09-01
Last Split Type	Reverse
Ma150	13.71
Ma150ch	79.87%
Ma20	18.64
Ma20ch	32.34%
Net CF	-454,000
Next Earnings Date	2026-06-25
Open	21
Position In Range	99.93
Ppne	3,166,000
Price Date	2026-05-08
Price EBITDA	GBX 54.76
Ptbv Ratio	2.29
Relative Volume	2.14x
Revenue	4,459,336x
SBC By Revenue	2.56x
Share Based Comp	114,000
Tax By Revenue	-0.04x
Tr20y	-94.7%
Tr6m	86.17%
Volume	816,252
Z Score	0.2

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does AIM/RUA pay a dividend?

Capital-return profile for this ticker.

Performance

AIM/RUA stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns AIM/RUA?

Insider, institutional, and short-interest positioning.

Institutional ownership

+62.0%

Share of float held by funds and institutions

Insider ownership

+13.7%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+42.6%

Negative means the company is buying back shares.

Technical

AIM/RUA momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

83.4

Above 70: short-term overbought

Price vs 200-day MA

+87.2%

50/200-day relationship not available

Beta (5Y)

0.97

Moves roughly with the market

Sharpe ratio

1.71

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About AIM/RUA

Hub-level FAQ points readers to the deeper analysis pages.

What is the current aim/RUA stock rating?

aim/RUA is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full aim/RUA analysis?

The full report lives at /stocks/aim/RUA/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for aim/RUA?

The latest report frames aim/RUA around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the aim/RUA page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.